Only logged-in users can see full content details
ZAGREB, 23 June (Hina) - Croatia is about two years behind Slovenia in the availability of new drugs for multiple myeloma, which is why the MijelomCRO association sent an appeal to the health administration on Tuesday for a more effective fight against the second most common blood cancer, with at least person diagnosed with the disease every day.